The landscape of dementia prognosis has developed considerably with the advent of refined biomarkers, which include amyloid PET scans, tau imaging, and blood-primarily based tests that could detect Alzheimer's pathology a long time before signs and symptoms emerge. Whilst these technological advances represent outstanding progress in being familiar with neurodegenerative https://mentalhealthinolderadults51482.idblogmaker.com/37025148/the-enduring-value-of-cognitive-evaluation-for-older-adults